Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Genetic Dissection of Trisomy 21-TMD Using Human Pluripotent Stem Cells	Boston Children's Hospital / Glenn MacLean	Young Investigator Grants	2013	Massachusetts
Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21	Dana-Farber Cancer Institute / Andrew Lane, MD, PhD	Young Investigator Grants	2013	Massachusetts
Investigating the Role of Circadian Rhythm in the Progression of Acute Myeloid Leukemia	Boston Children's Hospital / Samantha Morris, PhD	Young Investigator Grants	2013	Massachusetts
Oncogenic Hedgehog Pathway Activation by a Putative Rho GTPase-Activating Protein	Lucile Packard Children's Hospital at Stanford University School of Medicine / Jun Ni, PhD	Young Investigator Grants	2013	California
Dissecting the Hierarchy of Tumor Cell Differentiation Using Dual Recombinase Technology in a Novel Mouse Model of Rhabdomyosarcoma	Duke University Medical Center / David Van Mater, MD, PhD	Young Investigator Grants	2013	North Carolina
Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers	Dana-Farber Cancer Institute / Charles Roberts, MD, PhD	Innovation Grants	2013	Massachusetts
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1	Dana-Farber Cancer Institute / Loren Walensky, MD, PhD	Innovation Grants	2013	Massachusetts
Genetic Alterations in Intramedullary Spinal Cord Tumors	The Johns Hopkins University School of Medicine / George Jallo, MD	Innovation Grants	2013	Maryland
Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma	Columbia University Medical Center / Darrell Yamashiro, MD, PhD	Innovation Grants	2013	New York
Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma	Duke University / Corinne Mary Linardic, MD, PhD	Innovation Grants	2013	North Carolina

Pages